Coffin-Lowry syndrome (CLS) is a rare genetic disorder caused by pathogenic variants in the RPS6KA3 gene, which encodes the RSK2 protein kinase. It is inherited in an X-linked dominant pattern and is characterized by developmental delay, intellectual disability, distinctive facial features, and skeletal abnormalities, with the condition generally being more pronounced in males than in females.
Coffin–Lowry syndrome
The RPS6KA3 gene (ribosomal protein S6 kinase A3) is located on the X chromosome and encodes the RSK2 protein, a kinase involved in the MAPK/ERK signaling pathway. This pathway participates in signal transmission from the cell surface to the nucleus and regulates processes such as neuronal differentiation, synaptic plasticity, learning, memory, and the growth of different tissues. Pathogenic variants in RPS6KA3 reduce or abolish RSK2 function, altering essential signaling pathways during the development of the central nervous system and the skeleton. In hemizygous males, the disease typically results in moderate or severe intellectual disability and characteristic clinical features; in heterozygous females, expression is highly variable, ranging from mild forms to more overt manifestations, partly due to X chromosome inactivation. Most described cases are sporadic or de novo, although familial transmission can also occur. The estimated prevalence is low, around 1 in 40,000-50,000 males, with no clearly established ethnic predilection.
Symptoms
Signs usually become evident during childhood, as motor and language delay is observed. In males, intellectual disability, hypotonia, short stature, progressively more characteristic facial features, small hands with broad or tapered fingers, and skeletal anomalies such as kyphosis or scoliosis are frequent. Some patients present with stimulus-induced falling episodes, especially noise or startle, as well as seizures, auditory disturbances, sleep apnea, or cardiac complications. In females, the phenotype can be milder and more variable.
Disease management
There is no curative treatment for Coffin-Lowry syndrome, so management is symptomatic and multidisciplinary. Early intervention programs, physical therapy, occupational therapy, speech therapy, and individualized educational support are recommended. Seizures and drop attacks are treated according to their clinical presentation, and skeletal abnormalities, especially progressive scoliosis, require orthopedic monitoring and, in some cases, surgery. Cardiologic, auditory, respiratory, and developmental surveillance, as well as family genetic counseling, are also advised.
Genes analyzed
Bibliography
Lv Y, Zhu L, Zheng J, et al. Growth Concerns in Coffin-Lowry Syndrome: A Case Report and Literature Review. Front Pediatr. 2019 Jan 25;6:430.
Fung JLF, Rethanavelu K, Luk HM, et al. Coffin-Lowry syndrome in Chinese. Am J Med Genet A. 2019 Oct;179(10):2043-2048.
Kim JS, Ilaria S, Hundal J, et al. Coffin-Lowry Syndrome: A Case of Clinical Convergence for Psychology, Neuropsychology, Psychiatry, Genetics, and Neurology. J Child Neurol. 2025 May;40(5):374-378.
